CompoAtlas

Sodium Hyaluronate Suppositories 5mg

Natural health product licensed in Canada

Licence holder
CellChem Pharmaceuticals Inc.
NPN or DIN-HM
80094479
Status
Active licence
Licence date
19 September 2019
Revision date
Not provided
Form
Suppositoire
Route of administration
Vaginale
Application type
Non traditionnelle

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Acide hyaluronique, sel de sodium

Source : Streptococcus Equi-Bacterial Extracellular Capsule

5 mg
Acide hyaluronique, sel de sodium

Source : Hyaluronate de sodium

5 mg

Non-medicinal ingredients

Ext. de Calendula Officinalis, Glycérides de palme hydrogénés, Jus de feuilles d'Aloe Barbadensis, Glycérides de palmiste hydrogénes, Extrait de Centella asiatica, NA

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 suppositoire1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps relieve dryness and promote healing of vaginal mucosa in menopausal women.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80094479

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line